Another Short Seller Twitter Hoax Hits a High Flying Stock (SRPT) (ADNC)

Trading fraudsters are at it again Wednesday.

Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) fell out of bed mid-day after a Twitter account posing to be influential short selling firm Citron Research made a negative mention of the stock. The stock fell as much as 10 percent before recovering. Shares last traded up 3.5% to $28.13.

@citreonresearc
"$SRPT FDA steps in as its 48 weeks results on Eteplirsen results are tainted and have been doctored they believeTrial papers seized by FDA."

Twitter has since suspended this account.

A similar occurrence happened Tuesday when a Twitter account posing as Muddy Waters Research issued a tweet about Audience (NASDAQ: ADNC). The real Muddy Waters called it a "hoax." Shares of Audience plunged 24% intra-day before recovering and closing up 4.5%.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Vishay launches compact proximity sensor with 5 μA idle current
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'